Administration of the Combination Clonazepam-Deanxit as Treatment for Tinnitus

作者：Meeus Olivier^*; De Ridder Dirk; Van de Heyning Paul

来源：Otology & Neurotology, 2011, 32(4): 701-709.

DOI：10.1097/MAO.0b013e31820e737c

• Clonazepam
• Deanxit
• Flupentixol
• Melitracen
• Tinnitus

Hypothesis: Present study investigates the combination of Deanxit and clonazepam (Rivotril) intake for relief of tinnitus complaints, respecting a double-blind placebo-controlled approach for Deanxit in a crossover setup.
Background: Although several pharmacologic treatments- including antidepressants, prostaglandins, and aminobutyric acid (GABA)-active drugs-were already presented as promising in tinnitus treatment, no drug has yet been approved by the Food and Drug Administration and European Medicine Agency for the treatment of tinnitus.
Methods: Patients were randomly assigned to patient group A or patient group B in a double-blind way. Patient group A first received 3 weeks of Deanxit, followed by 1 week of washout and 3 weeks of placebo. Treatment was given in opposite order to subjects from Patient group B. All patients received a daily treatment consisting of clonazepam 1 mg once daily, starting on Day 1.
Results: Significant tinnitus reduction was seen after intake of the combination clonazepam-Deanxit, whereas no differences in tinnitus could be demonstrated after the administration of clonazepam-placebo. This was true for all patients according to the following parameters: time patients are annoyed by the tinnitus (p = 0.026) and the visual analogue scale for tinnitus annoyance (p = 0.024).
Conclusion: Although tinnitus reduction was recorded as modest, this article provides valuable data demonstrating a placebo-controlled tinnitus reduction after clonazepam and Deanxit intake.

• 出版日期2011-6